Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children-Reference-Cited by-同舟云学术

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children

Published:2018-03-02 Issue:9 Volume:217 Page:1338-1346
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Buchholz Ursula J¹,Cunningham Coleen K²,Muresan Petronella³,Gnanashanmugam Devasena⁴,Sato Paul⁴,Siberry George K⁵,Rexroad Vivian⁶,Valentine Megan⁷,Perlowski Charlotte⁷,Schappell Elizabeth⁸,Thumar Bhagvinji⁸,Luongo Cindy¹,Barr Emily⁹¹⁰,Aziz Mariam¹¹,Yogev Ram¹²,Spector Stephen A¹³,Collins Peter L¹,McFarland Elizabeth J⁹¹⁰,Karron Ruth A⁸,

Affiliation:

1. RNA Viruses Section, Laboratory of Infectious Diseases, Bethesda

2. Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina

3. Harvard T. H. Chan School of Public Health, Boston, Massachusetts

4. Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda

5. Maternal Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda

6. Johns Hopkins Hospital

7. FHI 360, Durham, North Carolina

8. Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

9. Department of Pediatric Infectious Diseases, Aurora, Colorado

10. Mucosal and Vaccine Research Program Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado

11. Rush University Medical Center, Chicago, Illinois

12. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois

13. Clinical Trials Unit, International Maternal Pediatric Adolescent AIDS Clinical Trials Group, University of California, San Diego, California

Funder

National Institute of Mental Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/217/9/1338/25090356/jiy066.pdf

Reference33 articles.

1. Social, economic, and health impact of the respiratory syncytial virus: a systematic search;Díez-Domingo;BMC Infect Dis,2014

2. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;Nair;Lancet,2010

3. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants;Pediatrics,1998

4. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine;Kim;Am J Epidemiol,1969

5. The impact of respiratory syncytial virus disease prevention on pediatric asthma;Caballero;Pediatr Infect Dis J,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges;ACS Nano;2024-08-26

2. Clinical research on RSV prevention in children and pregnant women: progress and perspectives;Frontiers in Immunology;2024-01-24

3. Situación actual de las vacunas atenuadas intranasales frente al virus respiratorio sincitial en la población infantil;Vacunas;2024-01

4. Current situation of intranasal attenuated vaccines against respiratory syncytial virus in the child population;Vacunas (English Edition);2024-01

5. Viral Infections of the Fetus and Newborn;Avery's Diseases of the Newborn;2024